Aims European and American guidelines have recommended salt and fluid restriction for patients with chronic heart failure (CHF) despite scarce scientific evidence. Therefore, we investigated the ...

In this study, salt and fluid restrictions were associated with a ... and lowered dose of diuretics, in patients with CHF. We believe the effects of the intervention were obtained because ...

At any given time, 80 to 90% of patients are getting ESA therapy and ... In other countries, HIF-PHIs are approved for non-dialysis CKD-related anemia.

particularly careful fluid management through ultrafiltration, may reduce reliance on antihypertensives and improve survival rates in dialysis patients. The results underscore the importance of ...

(1) Chronic kidney disease (CKD) poses a significant burden on patients across all stages, with immune dysfunction contributing to a heightened vulnerability to infections. As CKD progresses, immune ...

Patients with chronic kidney disease and those who have had a kidney transplant should avoid high doses of vitamin D, according to an evidence-based consensus document.

Compared with standard blood pressure control, treating patients with CKD to an intensive blood pressure target reduces cardiovascular risks, with a tradeoff of an increase in adverse events. The ...

AZ said that the decision is a "milestone" in the treatment of CKD, becoming the first new treatment option for patients in nearly 20 years, although it cautioned that the recommendations as they ...

has announced the publication of a review in the Journal of Nephrological Science that explores patient perspectives on phosphate management in chronic kidney disease (CKD). The review highlights ...

Rilparencel is ProKidney’s main candidate. It is intended as a therapy that stabilizes kidneys, making it potentially useful for CKD patients. We’ll have Rilparencel’s Phase 2 full data in ...